Document is current
Any future updates will be listed below
-
Authors
Possemis, Nina https://orcid.org/0000-0002-7279-4052
Caldenhove, Stéphanie https://orcid.org/0000-0002-5058-5380
Prickaerts, Jos https://orcid.org/0000-0001-5548-731X
Blokland, Arjan https://orcid.org/0000-0002-4337-7479
- License Information
-
More Information
Article History
Received: 25 June 2024
Accepted: 14 October 2024
First Online: 24 October 2024
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: AB and JP have a proprietary interest in the PDE4 inhibitor roflumilast for the treatment of cognitive impairment.
